Peter Šebo

7.0k total citations
166 papers, 5.7k citations indexed

About

Peter Šebo is a scholar working on Microbiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Peter Šebo has authored 166 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Microbiology, 74 papers in Molecular Biology and 47 papers in Epidemiology. Recurrent topics in Peter Šebo's work include Bacterial Infections and Vaccines (103 papers), Escherichia coli research studies (40 papers) and Bacterial Genetics and Biotechnology (28 papers). Peter Šebo is often cited by papers focused on Bacterial Infections and Vaccines (103 papers), Escherichia coli research studies (40 papers) and Bacterial Genetics and Biotechnology (28 papers). Peter Šebo collaborates with scholars based in Czechia, France and Belarus. Peter Šebo's co-authors include Radim Osička, Jiří Mašín, Daniel Ladant, Claude Leclerc, Ladislav Bumba, Jana Kamanová, Irena Linhartová, Adriana Osic̆ková, Marek Basler and Roland Benz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Peter Šebo

162 papers receiving 5.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Šebo 2.7k 2.5k 1.3k 1.2k 1.2k 166 5.7k
Mumtaz Virji 3.5k 1.3× 1.8k 0.7× 1.7k 1.2× 985 0.8× 596 0.5× 104 5.6k
Eric T. Harvill 2.5k 0.9× 1.2k 0.5× 1.6k 1.2× 587 0.5× 834 0.7× 142 4.2k
Matthias Frosch 4.1k 1.5× 3.0k 1.2× 3.6k 2.7× 1.3k 1.1× 1.2k 1.0× 240 10.2k
H. Steven Seifert 3.7k 1.4× 3.6k 1.5× 1.1k 0.8× 683 0.6× 754 0.6× 139 7.7k
John E. Heckels 3.5k 1.3× 1.2k 0.5× 1.8k 1.3× 712 0.6× 376 0.3× 126 4.7k
Robert S. Munson 2.6k 1.0× 1.8k 0.7× 1.8k 1.3× 478 0.4× 654 0.5× 115 5.3k
Xavier Nassif 3.5k 1.3× 3.6k 1.4× 3.0k 2.2× 906 0.7× 2.2k 1.8× 193 10.8k
J Swanson 3.0k 1.1× 1.5k 0.6× 987 0.7× 619 0.5× 522 0.4× 70 4.9k
Scott Stibitz 1.6k 0.6× 1.8k 0.7× 658 0.5× 435 0.4× 893 0.7× 85 3.6k
Meta Kuehn 5.5k 2.1× 5.3k 2.1× 2.5k 1.9× 1.2k 1.0× 2.3k 1.9× 75 11.1k

Countries citing papers authored by Peter Šebo

Since Specialization
Citations

This map shows the geographic impact of Peter Šebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Šebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Šebo more than expected).

Fields of papers citing papers by Peter Šebo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Šebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Šebo. The network helps show where Peter Šebo may publish in the future.

Co-authorship network of co-authors of Peter Šebo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Šebo. A scholar is included among the top collaborators of Peter Šebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Šebo. Peter Šebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barkoff, Alex‐Mikael, et al.. (2025). Alterations in the expression of Bordetella pertussis antigens in relation to the use of acellular pertussis vaccine in Finland. Vaccine. 58. 127279–127279. 1 indexed citations
3.
Staněk, Ondřej, et al.. (2025). Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection. mSphere. 10(4). e0063924–e0063924. 2 indexed citations
5.
Kapil, Parul, et al.. (2024). A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge. mSphere. 9(11). e0064724–e0064724. 2 indexed citations
6.
Osic̆ková, Adriana, Ladislav Bumba, Petr Man, et al.. (2023). A conserved tryptophan in the acylated segment of RTX toxins controls their β2 integrin–independent cell penetration. Journal of Biological Chemistry. 299(8). 104978–104978. 2 indexed citations
7.
Soumana, Illiassou Hamidou, Kalyan K. Dewan, Bodo Linz, et al.. (2022). Modeling the catarrhal stage of Bordetella pertussis upper respiratory tract infections in mice. Disease Models & Mechanisms. 15(5). 5 indexed citations
8.
Juhász, Attila, Jiří Mašín, Ondřej Staněk, et al.. (2021). Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of Bordetella pertussis. International Journal of Molecular Sciences. 22(21). 11655–11655. 4 indexed citations
9.
Barkoff, Alex‐Mikael, et al.. (2021). Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis. Diagnostics. 11(2). 180–180. 3 indexed citations
10.
Bumba, Ladislav, Pavel Srb, Václav Veverka, et al.. (2020). Negative charge of the AC-to-Hly linking segment modulates calcium-dependent membrane activities of Bordetella adenylate cyclase toxin. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(9). 183310–183310. 9 indexed citations
11.
Pouchnik, Derek, Mark R. Wildung, Fabian Amman, et al.. (2018). Comparative genomics of Czech vaccine strains of Bordetella pertussis. Pathogens and Disease. 76(7). 8 indexed citations
12.
Arciniega, Juan, Roman Prymula, Peter Šebo, et al.. (2016). Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement: Report on an international workshop. PubMed Central. 2015. 82. 2 indexed citations
13.
Wald, Tomáš, Adriana Osic̆ková, Jiří Mašín, et al.. (2016). Transmembrane segments of complement receptor 3 do not participate in cytotoxic activities but determine receptor structure required for action ofBordetellaadenylate cyclase toxin. Pathogens and Disease. 74(3). ftw008–ftw008. 11 indexed citations
14.
Bumba, Ladislav, Jiří Mašín, Pavel Macek, et al.. (2016). Calcium-Driven Folding of RTX Domain β-Rolls Ratchets Translocation of RTX Proteins through Type I Secretion Ducts. Molecular Cell. 62(1). 47–62. 125 indexed citations
15.
Dong, Hui, Ondřej Staněk, Francesc Rudilla, et al.. (2012). Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells. Mucosal Immunology. 6(3). 522–534. 19 indexed citations
16.
Kamanová, Jana, Olga Kofroňová, Jiří Mašín, et al.. (2008). Adenylate Cyclase Toxin Subverts Phagocyte Function by RhoA Inhibition and Unproductive Ruffling. The Journal of Immunology. 181(8). 5587–5597. 91 indexed citations
17.
Knapp, Oliver, Elke Maier, Jiří Mašín, Peter Šebo, & Roland Benz. (2007). Pore formation by the Bordetella adenylate cyclase toxin in lipid bilayer membranes: Role of voltage and pH. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(1). 260–269. 18 indexed citations
18.
Majlessi, Laleh, Marcela Simsova, Priscille Brodin, et al.. (2006). An Increase in Antimycobacterial Th1-Cell Responses by Prime-Boost Protocols of Immunization Does Not Enhance Protection against Tuberculosis. Infection and Immunity. 74(4). 2128–2137. 86 indexed citations
19.
Schlecht‐Louf, Géraldine, et al.. (2004). Antigen Targeting to CD11b Allows Efficient Presentation of CD4+ and CD8+ T Cell Epitopes and In Vivo Th1-Polarized T Cell Priming. The Journal of Immunology. 173(10). 6089–6097. 59 indexed citations
20.
Mašín, Jiří, Ivo Konopásek, Jaroslava Svobodová, & Peter Šebo. (2003). Different structural requirements for adenylate cyclase toxin interactions with erythrocyte and liposome membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1660(1-2). 144–154. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026